A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Public ClinicalTrials.gov record NCT07193563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The ENCalmSocial Trial: A Randomized, Double-Blind, Placebo-Controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a double-blind study to evaluate the efficacy and safety of ENX-102 in participants with social anxiety disorder (SAD).
Study identification
- NCT ID
- NCT07193563
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 47 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 5, 2025 (Actual)
- Primary completion
- Mar 19, 2026 (Actual)
- Completion
- Mar 19, 2026 (Actual)
- Last update posted
- Apr 8, 2026
2025 – 2026
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| IMA Clinical Research Phoenix | Phoenix | Arizona | 85012 | — |
| University of California | La Jolla | California | 92037 | — |
| Neuroresearch Group | Los Angeles | California | 90025 | — |
| Excell Research, Inc. | Oceanside | California | 92056 | — |
| Anderson Clinical Research | Redlands | California | 92374 | — |
| California Neuroscience Research, LLC | Sherman Oaks | California | 91403 | — |
| Sunwise Clincial Research | Walnut Creek | California | 94596 | — |
| Mountain View Clinical Research | Denver | Colorado | 80209 | — |
| CNS Health | Jacksonville | Florida | 32256 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32801 | — |
| CenExel iResearch, LLC | Savannah | Georgia | 31405 | — |
| IMA Clinical Research | Las Vegas | Nevada | 89102 | — |
| Redbird Research | Las Vegas | Nevada | 89119 | — |
| Cenexel HRI | Berlin | New Jersey | 08009 | — |
| SPRI Clinical Trials, LLC | Brooklyn | New York | 11235 | — |
| Neurobehavioral Research, Inc. | Cedarhurst | New York | 11516 | — |
| Clinical Neurosciences, Inc | Memphis | Tennessee | 38119 | — |
| Austin Clinical Trials Partners | Austin | Texas | 78737 | — |
| Grayline Research Center | Wichita Falls | Texas | 76309 | — |
| Core Clinical Research | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07193563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07193563 live on ClinicalTrials.gov.